Verve Therapeutics, Inc. (VERV)

Verve Therapeutics Revenue

Verve Therapeutics had revenue of $6.87M in the quarter ending September 30, 2024, with 120.24% growth. This brings the company's revenue in the last twelve months to $24.40M, up 219.91% year-over-year. In the year 2023, Verve Therapeutics had annual revenue of $11.76M with 505.77% growth.

• Revenue (ttm): $24.40M
• Revenue Growth: +219.91%
• P/S Ratio: 21.66
• Revenue / Employee: $95,671
• Employees: 255
• Market Cap: 556.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	11.76M	9.82M	505.77%
Dec 31, 2022	1.94M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.